Home

Laut sprechen Zivilisieren Koch ipsc diabetes Erhebt euch Reiniger Schlichter

Applications of iPSC-derived beta cells from patients with diabetes -  ScienceDirect
Applications of iPSC-derived beta cells from patients with diabetes - ScienceDirect

Generation of pancreatic β cells for treatment of diabetes: advances and  challenges | Stem Cell Research & Therapy | Full Text
Generation of pancreatic β cells for treatment of diabetes: advances and challenges | Stem Cell Research & Therapy | Full Text

Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy  using Human Induced Pluripotent Stem Cells
Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells

Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy  using Human Induced Pluripotent Stem Cells - ScienceDirect
Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells - ScienceDirect

Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs,  more - The Niche
Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more - The Niche

Evotec und Sernova geben exklusive strategische Partnerschaft zur  Entwicklung einer iPSC-basierten Betazell-Ersatztherapie gegen Diabetes  bekannt
Evotec und Sernova geben exklusive strategische Partnerschaft zur Entwicklung einer iPSC-basierten Betazell-Ersatztherapie gegen Diabetes bekannt

Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived  Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant
Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant

Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus

A schematic representation of the iPSC generation from the diabetic... |  Download Scientific Diagram
A schematic representation of the iPSC generation from the diabetic... | Download Scientific Diagram

Towards a better understanding of diabetes mellitus using organoid models |  Nature Reviews Endocrinology
Towards a better understanding of diabetes mellitus using organoid models | Nature Reviews Endocrinology

A schematic representation of the iPSC generation from the diabetic... |  Download Scientific Diagram
A schematic representation of the iPSC generation from the diabetic... | Download Scientific Diagram

Generation of stem cell-derived β-cells from patients with type 1 diabetes  | Nature Communications
Generation of stem cell-derived β-cells from patients with type 1 diabetes | Nature Communications

Gene-edited human stem cell–derived β cells from a patient with monogenic  diabetes reverse preexisting diabetes in mice | Science Translational  Medicine
Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice | Science Translational Medicine

Generation of pancreatic β cells for treatment of diabetes: advances and  challenges | Stem Cell Research & Therapy | Full Text
Generation of pancreatic β cells for treatment of diabetes: advances and challenges | Stem Cell Research & Therapy | Full Text

A schematic representation of the iPSC generation from the diabetic... |  Download Scientific Diagram
A schematic representation of the iPSC generation from the diabetic... | Download Scientific Diagram

Human iPS Cell Line (Type 2 Diabetes) - Cell Model Expert | iPSC | Primary  Cells
Human iPS Cell Line (Type 2 Diabetes) - Cell Model Expert | iPSC | Primary Cells

Frontiers | Use of Induced Pluripotent Stem Cells to Build Isogenic Systems  and Investigate Type 1 Diabetes
Frontiers | Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes

Engineering islets from stem cells for advanced therapies of diabetes |  Nature Reviews Drug Discovery
Engineering islets from stem cells for advanced therapies of diabetes | Nature Reviews Drug Discovery

Replacing what was lost: A novel cell therapy for type I diabetes mellitus  - Institute of Industrial Science, the University of Tokyo
Replacing what was lost: A novel cell therapy for type I diabetes mellitus - Institute of Industrial Science, the University of Tokyo

The use of cellular reprogramming and genome editing for experimental... |  Download Scientific Diagram
The use of cellular reprogramming and genome editing for experimental... | Download Scientific Diagram

Scientists Make Insulin-Secreting Cells from Stem Cells of Type 1 Diabetes  Patients | The Stem Cellar
Scientists Make Insulin-Secreting Cells from Stem Cells of Type 1 Diabetes Patients | The Stem Cellar

Diabetes Mellitus and iPSC-Based Therapy | SpringerLink
Diabetes Mellitus and iPSC-Based Therapy | SpringerLink

Applications of iPSC-derived beta cells from patients with diabetes -  ScienceDirect
Applications of iPSC-derived beta cells from patients with diabetes - ScienceDirect

Frontiers | Human Pluripotent Stem Cells Go Diabetic: A Glimpse on  Monogenic Variants
Frontiers | Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants

Frontiers | Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology
Frontiers | Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology

Advancing diabetes research and drug development with human iPSC-derived  beta cells
Advancing diabetes research and drug development with human iPSC-derived beta cells

Modelling monogenic diabetes with human pluripotent stem cells - Media  Centre | EASD
Modelling monogenic diabetes with human pluripotent stem cells - Media Centre | EASD

Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal  TGFβ signaling in type 2 diabetes mellitus - Journal of Molecular and  Cellular Cardiology
Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus - Journal of Molecular and Cellular Cardiology